Association of polymorphisms in SPARC and NLRP2 genes with rheumatoid arthritis in a Chinese Han population

References

• Fueki H, Hino R, Yoshioka M, Nakamura M, Tokura Y. Calcinosis cutis associated with primary Sjogren's syndrome: strong expression of osteonectin and matrix Gla protein. Rheumatology (Oxford). 2011;50(12):2318–20.
   PubMed Web of Science ®Google Scholar
• Sharma SM, Choi D, Planck SR, Harrington CA, Austin CR, Lewis JA, et al. Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles. Arthritis Res Ther. 2009;11(6):R168.
   Web of Science ®Google Scholar
• Nakamura S, Kamihagi K, Satakeda H, Katayama M, Pan H, Okamoto H, et al. Enhancement of SPARC (osteonectin) synthesis in arthritic cartilage. Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures. Arthritis Rheum. 1996;39(4): 539–51.
   Google Scholar
• Pontillo A, Girardelli M, Kamada AJ, Pancotto JA, Donadi EA, Crovella S, Sandrin-Garcia P. Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity. 2012;45(4):271–78.
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Wang Y, Hasegawa M, Imamura R, Suda T. PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1beta secretion. J Biol Chem. 2005;280(23):21720–25.
   PubMed Web of Science ®Google Scholar
• Fontalba A, Gutierrez O, Fernandez-Luna JL. NLRP2, an inhibitor of the NF-kappaB pathway, is transcriptionally activated by NF-kappaB and exhibits a nonfunctional allelic variant. J Immunol. 2007;179(12):8519–24.
   PubMed Web of Science ®Google Scholar
• Bruey JM, Bruey-Sedano N, Newman R, Chandler S, Stehlik C, Reed JC. PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kappaB and caspase-1 activation in macrophages. J Biol Chem. 2004;279(50):51897–907.
   PubMed Web of Science ®Google Scholar
• Saklatvala J, Sarsfield SJ, Townsend Y. Pig interleukin 1. Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation, and fever. J Exp Med. 1985;162(4):1208–22.
   Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.
   PubMed Web of Science ®Google Scholar
• Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15(2):97–98.
   PubMed Web of Science ®Google Scholar
• Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, Martin GR. Osteonectin, a bone-specific protein linking mineral to collagen. Cell. 1981;26(1 Pt 1):99–105.
   PubMed Web of Science ®Google Scholar
• Lorenzo J, Horowitz M, Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008;29(4):403–40.
   PubMed Web of Science ®Google Scholar
• Rempel SA, Hawley RC, Gutierrez JA, Mouzon E, Bobbitt KR, Lemke N, et al. Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response. Genes Immun. 2007;8(3):262–74.
   PubMed Web of Science ®Google Scholar
• Tremble PM, Lane TF, Sage EH, Werb Z. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol. 1993; 121(6):1433–44.
   PubMed Web of Science ®Google Scholar
• Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH. SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol. 1994;125(4):929–43.
   PubMed Web of Science ®Google Scholar
• Mundlos S, Schwahn B, Reichert T, Zabel B. Distribution of osteonectin mRNA and protein during human embryonic and fetal development. J Histochem Cytochem. 1992;40(2):283–91.
   PubMed Web of Science ®Google Scholar
• Malaval L, Fournier B, Delmas PD. Radioimmunoassay for osteonectin. Concentrations in bone, nonmineralized tissues, and blood. J Bone Miner Res. 1987;2(5):457–65.
   PubMed Web of Science ®Google Scholar
• Jundt G, Berghauser KH, Termine JD, Schulz A. Osteonectin–a differentiation marker of bone cells. Cell Tissue Res. 1987;248(2): 409–15.
   PubMed Web of Science ®Google Scholar
• Pacifici M, Oshima O, Fisher LW, Young MF, Shapiro IM, Leboy PS. Changes in osteonectin distribution and levels are associated with mineralization of the chicken tibial growth cartilage. Calcif Tissue Int. 1990;47(1):51–61.
   PubMed Web of Science ®Google Scholar
• Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis. 1989;48(8):645–53.
   PubMed Web of Science ®Google Scholar
• Vuorio T, Kahari VM, Black C, Vuorio E. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea. J Rheumatol. 1991;18(2):247–51.
   PubMed Web of Science ®Google Scholar
• Pawlowski K, Pio F, Chu Z, Reed JC, Godzik A. PAAD – a new protein domain associated with apoptosis, cancer and autoimmune diseases. Trends Biochem Sci. 2001;26(2):85–7.
   PubMed Web of Science ®Google Scholar
• Iwamoto M, Koike T, Nakashima K, Sato K, Kato Y. Interleukin 1: a regulator of chondrocyte proliferation. Immunol Lett. 1989;21(2): 153–56.
   PubMed Web of Science ®Google Scholar
• Goldring MB, Birkhead J, Sandell LJ, Kimura T, Krane SM. Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest. 1988;82(6):2026–37.
   PubMed Web of Science ®Google Scholar